

Fetal Bovine Serum for Life Sciences Market Scope:
Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
The global Fetal Bovine Serum for Life Sciences market is projected to reach a value of $1.2 billion by 2025, with a CAGR of 6.5%. Increasing demand for cell culture media and biopharmaceutical products is driving market growth. North America is the largest market due to technological advancements and research activities. Request Sample Report
Companies Covered (Covid 19 Impact Covered)
◍ Thermo Fisher
◍ GE Healthcare
◍ Merck
◍ Moregate BioTech
◍ Gemini
◍ Atlanta Biologicals
◍ Tissue Culture Biologicals
◍ Bovogen
◍ Biowest
The competitive landscape of the Fetal Bovine Serum for Life Sciences Market includes key players such as Thermo Fisher, GE Healthcare, Merck, Moregate BioTech, Gemini, Atlanta Biologicals, Tissue Culture Biologicals, Bovogen, and Biowest. These companies utilize Fetal Bovine Serum for various life science applications, contributing to the overall growth of the market.
- Thermo Fisher: Sales revenue of $24.38 billion
- Merck: Sales revenue of $17.42 billion
- GE Healthcare: Sales revenue of $19.83 billion
Request Sample Report
◍ Scientific Research
◍ North America-sourced
◍ Industrial Production Request Sample Report
◍ South America-sourced
◍ Australia-sourced
◍ Others